Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma.

Ding, Yiming; Liu, Hanjie; Zhang, Chuanbao; Bao, Zhaoshi; Yu, Shuqing

Ding, Yiming; Liu, Hanjie; Zhang, Chuanbao; Bao, Zhaoshi; Yu, Shuqing.

Afiliación

Ding Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Liu H; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Zhang C; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bao Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yu S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Aging (Albany NY) ; 14(5): 2320-2334, 2022 03 07.

Article en En | MEDLINE | ID: mdl-35256538

Asunto(s)

Glioblastoma; Biomarcadores; Proteínas de Ciclo Celular/metabolismo; Glioblastoma/patología; Humanos; Pronóstico; Estudios Prospectivos; Proteínas Serina-Treonina Quinasas/genética

Palabras clave

ON1231320; biomarker; glioblastoma; polo-like kinases; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google